Top Clinical Trials companies in Denmark by Price to Earnings Ratio (P/E)

This ranking features the top 17 Clinical Trials companies in Denmark ranked by Price to Earnings Ratio (P/E), averaging a Price to Earnings Ratio (P/E) of -8.99, for July 06, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Clinical Trials company in Denmark has the highest Price to Earnings Ratio (P/E) ?

The Clinical Trials company in Denmark with the highest Price to Earnings Ratio (P/E) is ChemoMetec A/S (Copenhagen Stock Exchange: CHEMM.CO) at 78.22.

Which Clinical Trials company in Denmark has the lowest Price to Earnings Ratio (P/E) ?

The Clinical Trials company in Denmark with the lowest Price to Earnings Ratio (P/E) is 2cureX AB (publ) (Stockholm Stock Exchange: 2CUREX.ST) at None.

What are the top 10 Clinical Trials companies in Denmark by Price to Earnings Ratio (P/E) ?

The top 10 Clinical Trials companies in Denmark by Price to Earnings Ratio (P/E) are ChemoMetec A/S, ALK-Abelló A/S, Novo Nordisk A/S, Bavarian Nordic A/S, H. Lundbeck A/S, Genmab A/S, Saniona AB (publ), IO Biotech, Inc., ViroGates A/S and FluoGuide A/S.

What are the bottom 10 Clinical Trials companies in Denmark by Price to Earnings Ratio (P/E) ?

The bottom 10 Clinical Trials companies in Denmark by Price to Earnings Ratio (P/E) are 2cureX AB (publ), Initiator Pharma A/S, Gubra A/S, Danish Aerospace Company A/S, Ascendis Pharma A/S, Zealand Pharma A/S, BioPorto A/S, FluoGuide A/S, ViroGates A/S and IO Biotech, Inc..